Company Monitoring Page for JNJ

latest headlines for company on cafepharma

Buy This Pharma Giant Now For A 30% Return In 2013
Seeking Alpha
Wed, 05/30/12 - 03:04 pm
Tags:
JNJ, Bayer, Pfizer, Ranbaxy, Bristol-Myers Squibb
Is Dendreon's Downgrade Deserved?
Motley Fool
Wed, 05/30/12 - 10:20 am
Tags:
Dendreon, downgrades, Provenge, prostate cancer, JNJ, Zytiga
Johnson & Johnson says FDA did not approve once-per-day version of HIV pill Prezista
Yahoo/AP
Tue, 05/29/12 - 04:48 pm
Tags:
FDA, HIV, JNJ, Prezista
ASCO Stocks To Consider This Week
Seeking Alpha
Tue, 05/29/12 - 11:15 am
Tags:
ASCO, Arena Pharmaceuticals, Vivus, JNJ, Bayer, Onyx, Pharmacyclics
Have J&J's Approval Hopes Vanished?
Motley Fool
Mon, 05/28/12 - 11:16 am
Tags:
JNJ, bloodthinners, Xarelto
Johnson & Johnson Could Slip 5% On Lower Margins
Seeking Alpha
Fri, 05/25/12 - 10:02 am
Tags:
JNJ
Johnson & Johnson Setback Is Positive for Pfizer, Bristol-Myers
Minyanville
Thu, 05/24/12 - 12:49 pm
Tags:
Pfizer, JNJ, Bristol-Myers Squibb, Xarelto, bloodthinners
J&J's Xarelto likely delayed 3-12 months, not dead, says Leerink
The Fly on the Wall
Thu, 05/24/12 - 09:43 am
Tags:
bloodthinner, JNJ, Xarelto
FDA panel votes against new use for J&J's Xarelto
Yahoo/AP
Wed, 05/23/12 - 06:58 pm
Tags:
FDA, advisory panel, Xarelto, bloodthinners, JNJ
Weighing The Benefits Of Osiris' First Cell Therapy Approval
Seeking Alpha
Wed, 05/23/12 - 12:19 pm
Tags:
stem cells, Osiris, Advanced Cell Technologies, Aastrom Biosciences, NeoStem, JNJ, Dendreon, Prochymal
Report Card: Johnson & Johnson And Selected Peers
Seeking Alpha
Wed, 05/23/12 - 11:47 am
Tags:
JNJ, Abbott Laboratories, Bristol-Myers Squibb, Merck, Pfizer, Sanofi
Comparing 2 Dividend Plays In Healthcare
Seeking Alpha
Wed, 05/23/12 - 11:45 am
Tags:
dividends, Pfizer, JNJ
22 Biopharma Stocks With Breakout Potential in 2012
Seeking Alpha
Tue, 05/22/12 - 11:25 am
Tags:
Ziopharm, Zalicus, EXACT Sciences, Geron, Lexicon Pharmaceuticals, Nektar, Vical, Celgene, Celsion, ChemoCentryx, Clovis Oncology, Eli Lilly, JNJ, Pfizer, Elan, Biomarin, Biogen Idec, Auxilium, Arqule, Anthera, Acadia, Amicus Therapeutics, Vertex Pharmaceuticals
What You Must Know Before Investing in Prostate Cancer Stocks
Minyanville
Mon, 05/21/12 - 12:22 pm
Tags:
prostate cancer, Dendreon, Cougar Biotechnology, JNJ, Medivation, Exelixis
FDA staff sends mixed message on J&J drug Xarelto
Reuters
Mon, 05/21/12 - 12:20 pm
Tags:
FDA, JNJ, Xarelto, bloodthinners
China Biotech Week In Review: J&J Actively Pursuing M&A In China
Seeking Alpha
Sun, 05/20/12 - 12:33 pm
Tags:
JNJ, M&A, China National Biotech Group, Zhejiang Conba Pharma, Ningbo David Medical Device Co, Ventac Partners, Shanxi Zhendong Pharmaceutical Company, Bristol-Myers Squibb, Novozymes Biopharma, Zhejiang Hisun Pharma, ThermoDox
5 Pharmaceutical Stocks With Significant Exposure to Europe
Motley Fool
Fri, 05/18/12 - 10:54 am
Tags:
Europe, Merck, JNJ, Pfizer, Abbott Laboratories, Bristol-Myers Squibb
J&J Recall Watch: McNeil Recalls Imodium Lot
WSJ Online
Fri, 05/18/12 - 10:53 am
Tags:
JNJ, recalls, McNeil, Imodium
J&J’s Zytiga Helps Eliminate Early-Stage Prostate Cancer
Bloomberg
Thu, 05/17/12 - 10:16 am
Tags:
JNJ, Zytiga, prostate cancer
ASCO Preview: Eight Cancer Drugs to Watch at the Big Show
Xconomy
Wed, 05/16/12 - 12:27 pm
Tags:
ASCO, Genentech, T-DM1, breast cancer, tivozanib, Aveo, kidney cancer, Onyx, Bayer, regorafenib, colorectal cancer, Adcetris, Seattle Genetics, JNJ, prostate cancer, Zytiga, cabozantinib, Exelixis, Enzalutamide, Medivation, Ponatinib, chronic myeloid leukemia, Ariad Pharmaceuticals

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.